INS and metabolic dysfunction-associated steatotic liver disease: Weight loss has been shown substantial benefits not only for intrahepatic fat loss but also for improvement in metabolic parameters of glucose control and insulin sensitivity, whether NAFLD with overweight or normal weight (43).